High Purity (2R)-2-Deoxy-2-fluoro-2-methyl-D-erythropentonic Acid Gamma-Lactone 3,5-Dibenzoate: A Key Intermediate for Antiviral Synthesis

Discover the critical role of (2R)-2-Deoxy-2-fluoro-2-methyl-D-erythropentonic acid gamma-lactone 3,5-dibenzoate (CAS 874638-80-9) in advanced pharmaceutical synthesis. As a leading manufacturer and supplier in China, we provide this high-purity intermediate essential for developing next-generation antiviral therapies like Sofosbuvir.

Get a Quote & Sample

Key Advantages of Partnering with Us

Uncompromising Purity

Benefit from a guaranteed purity of ≥98.0% for your critical pharmaceutical intermediates, ensuring the efficacy and safety of your final drug products. We meticulously control our manufacturing processes.

Reliable Supply Chain

As a prominent supplier in China, NINGBO INNO PHARMCHEM CO.,LTD. ensures a stable and consistent supply of (2R)-2-Deoxy-2-fluoro-2-methyl-D-erythropentonic acid gamma-lactone 3,5-dibenzoate, crucial for uninterrupted production of life-saving medications.

Technical Expertise

Leverage our deep understanding of complex organic synthesis. We are your go-to manufacturer for specialty chemicals and pharmaceutical intermediates, providing expert support and competitive pricing.

Applications in Pharmaceutical Innovation

Sofosbuvir Synthesis

This compound is a vital reactant in the multi-step synthesis of Sofosbuvir, a cornerstone medication for treating Hepatitis C.

Pyrimidine Nucleoside Development

It serves as a key building block in the synthesis of various fluorinated pyrimidine nucleosides, which are essential for developing novel antiviral agents.

Antiviral Drug Manufacturing

The chemical properties and purity of this intermediate make it indispensable for the efficient and effective manufacturing of advanced antiviral pharmaceuticals.

Research & Development

For R&D scientists and product formulators, this high-quality intermediate offers a reliable starting point for exploring new therapeutic compounds and optimizing synthesis routes.